Mid-Atlantic Section of the American Urological Association
Home | About Us | Contact Us   
  Home
  Members
    Members Only Area
    Member Directory
    Join the MA-AUA
  Annual Meeting
  Board of Directors
  Committees
  Careers
  Newsletters
  Visit the AUA
  Advocacy Efforts
  MAAUA Research
  Scholarship
Didusch Museum
About the Mid-Atlantic Section of the American Urological Association (MAAUA)

 
  Members Only
  Username
 
  Password
 
   Forgot Password?

 

67th Annual Meeting Abstracts


The Impact a Family History of Prostate Cancer has on PSA Recurrence-free Survival in Obese Men.
Benjamin M Brucker, Matthew J Resnick, *Meredith Bergey, Daniel Canter, *Seema Sonnad, Alan J Wein, Keith N Van Arsdalen, *S Bruce Malkowicz
University of Pennsylvania, Philadelphia, PA

Introduction: Obesity has been suggested as a risk factor for PSA recurrence in men after radical prostatectomy (RP). However a family history (FH) of prostate cancer has been shown not to increase this risk. We examined a prospectively maintained RP database (1991-2005) to determine the impact of FH on PSA recurrence-free survival (PSARFS) in obese men.
Materials & Methods: 2113 patients were analysis. FH of prostate cancer was defined as >1 primary or secondary relative with prostate cancer. PSA recurrence was defined as a postoperative elevation in serum PSA >0.2 ng/ml. Chi-square, Fisher's exact and T-tests were used to compare variables. Multivariate regression analysis was preformed to determine variables impact of on PSARFS.
Results: The mean follow-up was 62.2 months. The mean age and pathological Gleason score were 59.6 years and 6.5 respectively. 63% of men had no FH of prostate cancer, 19.8% had one relative with prostate cancer and 4.9% had >2 relatives with prostate cancer. FH was not an independent predictor of PSARFS on multivariate analysis. However, when subgroup analysis was performed, FH was a negative predictor of PSARFS in obese men, but not in non-obese men (HR=1.47, 95% CI 1.07, 2.04; p=0.02 and HR=0.80, 95% CI 0.42-1.43; p=0.45, respectively).
Conclusions: A FH of prostate cancer does not impact PSARFS after RP in non-obese men, but it does have a negative impact in obese men. More work is needed to define the potential biological mechanism of this relationship. Studies on hereditary prostate cancer should consider analyzing BMI data.


 

 

Copyright © 2012 Mid-Atlantic Section of the American Urological Association. All Rights Reserved.
Read Privacy Policy.